In-situ hybridization-based quantification of hTR: a possible biomarker in malignant melanoma.
about
MiR-21: an environmental driver of malignant melanoma?Melanocytic nevi and melanoma: unraveling a complex relationship.MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer.Detection of the Malaria causing Plasmodium Parasite in Saliva from Infected Patients using Topoisomerase I Activity as a Biomarker.
P2860
In-situ hybridization-based quantification of hTR: a possible biomarker in malignant melanoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
In-situ hybridization-based qu ...... omarker in malignant melanoma.
@en
In-situ hybridization-based qu ...... omarker in malignant melanoma.
@nl
type
label
In-situ hybridization-based qu ...... omarker in malignant melanoma.
@en
In-situ hybridization-based qu ...... omarker in malignant melanoma.
@nl
prefLabel
In-situ hybridization-based qu ...... omarker in malignant melanoma.
@en
In-situ hybridization-based qu ...... omarker in malignant melanoma.
@nl
P2860
P356
P1433
P1476
In-situ hybridization-based qu ...... iomarker in malignant melanoma
@en
P2093
Josephine Vagner
Magnus Stougaard
P2860
P304
P356
10.1111/HIS.12501
P577
2015-01-20T00:00:00Z